Zusammenfassung
Pflanzliche Antirheumatika werden erfolgreich insbesondere bei schmerzhaften Beschwerden bei entzündlichen oder degenerativen rheumatischen Erkrankungen eingesetzt. Eines dieser Phytopharmaka ist Phytodolor® (STW 1), eine fixe Kombination von Extrakten aus Pappelrinde und -blättern (Populus tremula), Eschenrinde (Fraxinus excelsior) sowie echtem Goldrutenkraut (Solidago virgaurea). Seine Wirkungen sowie die seiner Komponenten wurden in umfangreichen experimentellen und humanpharmakologischen Untersuchungen verifiziert. Sein Wirkspektrum umfasst antiphlogistische, antiödematöse, antioxidative und analgetische Eigenschaften und erscheint breiter als das synthetischer Antirheumatika. Die in verschiedenen rheumatischen Indikationen durchgeführten offenen klinischen Untersuchungen und randomisierten, placebo- oder verum-kontrollierten Doppelblindstudien bestätigen die pharmakologisch belegte Wirksamkeit des Präparates, unter anderem in der Einsparung nichtsteroidaler Antirheumatika (NSARs). STW 1 besitzt eine hohe Arzneimittelsicherheit. SCHLUSSFOLGERUNG: Phytodolor® (STW 1) ist eine realistische Alternative zu NSAR und zu Cyclooxygenase(COX)-2-Inhibitoren wie Rofecoxib.
Summary
Herbal antirheumatics are successfully used in painful inflammatory or degenerative rheumatic diseases. One of these herbal medicines is Phytodolor® (STW 1), a fixed combination of extracts from aspen leaves and bark (Populus tremula), common ash bark (Fraxinus excelsior), and golden rod herb (Solidago virgaurea). Its effects as well as those of its components have been verified in experimental and human pharmacological investigations. The mode of action of STW 1 includes antiinflammatory, antioedematous, antioxidative and analgesic properties, and it is considered to be broader than that of synthetic antirheumatics. Open clinical studies and randomised, placebo- or verum-controlled double-blind trials, performed in different subtypes of rheumatic diseases, confirm the pharmacological evidence of efficacy, such as by reducing the intake of non-steroidal antiinflammatory drugs (NSAIDs). STW 1 has a high drug safety. CONCLUSION: Phytodolor® (STW 1) is a reasonable alternative to NSAIDs and to cyclooxygenase(COX)-2-inhibitors such as rofecoxib.
References
Setty AR, Sigal H (2005) Herbal medications commonly used in the practice of rheumatology: mechanisms of action, efficacy, and side effects. Semin Arthritis Rheum 34: 773–784
Rao J, Mihaliak K, Kroenke K, Bradley J, Tierney W, Weinberger M (1999) Use of complementary therapies for arthritis among patients of rheumatologists. Ann Intern Med 131: 409–416
PDR (Physician's Desk Reference) for Herbal Medicines, 2nd ed.; edt. by Medical Economics Company, Montvale, New Jersey, USA, 2000, pages 51, 290 and 608
Rohnert U, Schneider W, Elstner EF (1998) Superoxidedependent and -independent nitrite formation from hydroxylamine: inhibition by plant extracts. Z Naturforsch 53: 241–249
Rohnert U, Koske D, Schneider W, Elstner EF (1998) Inhibition by Salix-extracts and Phytodolor® of copper-catalyzed oxidative destructions. Z Naturforsch 53c: 233–240
Kruedener S v, Schneider W, Elstner EF (1996) Effects of extracts from Populus tremula L., Solidago virgaurea L. and Fraxinus excelsior L. on various myeloperoxidase systems. Drug Res 46(II): 809–814
Hartwich I, Germann I, Kelber O, Müller J, Weiser D, Heinle H (2006) The antirheumatic phytomedicine STW 1 has antioxidative effects. Z Rheumatol 65(Suppl 1): 28
Meyer B, Schneider W, Elstner EF (1995) Antioxidative properties of alcoholic extracts from Fraxinus excelsior, Populus tremula and Solidago virgaurea. Drug Res 45(I): 174–176
Schempp H, Weiser D, Elstner EF (2000) Biochemical model reactions indicative of inflammatory processes-Activities of extracts from Fraxinus excelsior and Populus tremula. Drug Res 50(I ): 362–372
Schaser J, Bonaterra GA, Kelber O, Weiser D, Kinscherf R, Metz J (2006) Untersuchungen antiinflammatorischer Effekte des Phytopharmakons Phytodolor und seiner Einzelkomponenten in einem Monozyten-Testmodell. Perfusion 19: 76–77
Strehl E, Schneider W, Elstner EF (1995) Inhibition of dihydrofolate reductase activity by alcoholic extracts from Fraxinus excelsior, Populus tremula and Solidago virgaurea. Drug Res 45(I): 172–173
Hahn S, Hübner-Steiner U (1988) Treatment of painful rheumatic diseases with Phytodolor in comparison to placebo and Amuno treatment. Rheuma, Schmerz & Entzündung 8: 55–58
Schreckenberger F (1988) The treatment of epicondylitis with Phytodolor. Der praktische Arzt 42: 1638–1644
Huber B (1991) Therapy of degenerative rheumatic diseases – Requirement for additional analgesic medication under treatment with Phytodolor N. Fortschr Med 109: 248–250
Schadler W (1988) Phytodolor for the treatment of activated arthrosis. Rheuma 8: 288–290
Dunky A, Eberl R (1986) Treatment of rheumatic diseases with a plant-based antirheumatic. Therapiewoche 36: 3226–3228
Klose H-H (1988) A phytotherapeutic agent for post-operative pain treatment. Therapiewoche 38: 3584–3585
Speders S (1988) Phytodolor for the treatment of degenerative spinal diseases. Forum Dr.med. 7–8: 29–30
Reiter W, Frerick H, Schmidt U, Schenk N (1989) What does an antirheumatic agent composed of plant ingredients achieve in the therapy of chronic polyarthritis? Therapiewoche 39: 3409–3414
Holzgartner H, Schmidt U, Frerick H, Schenk N (1989) Experience with Phytodolor for the treatment of predominantly subacute rheumatic symptoms in a private internal medicine practice. Rheuma, Schmerz & Entzündung 9: 52–54
Michael J (1990) Treatment of rheumatic and degenerative joint diseases with Phytodolor N in orthopaedics. Rheuma-Schmerz & Entzündung 10: 34–38
Rauch G, Rauch S (1991) Rheumatic pain – Ash, American aspen (trembling poplar) and golden rod chase it away. Ärztl Praxis 5: 22–23
Gundermann K-J, Godehardt E, Ulbrich M (2007) Summarizing evaluation of randomized double-blind trials with Phytodolor N. Publication under Preparation
Ernst E (1999) The efficacy of Phytodolor® for the treatment of musculoskeletal pain – a systematic review of randomized clinical trials. Nat Med 2: 14–17
Ernst E, Chrubasik S (2000) Phyto-anti-inflammatories – a systematic review of randomized, placebo-controlled, double-blind trials. Complement Altern Ther Rheum Dis II 26: 13–27
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gundermann, KJ., Müller, J. Phytodolor® – Effects and efficacy of a Herbal Medicine. Wien Med Wochenschr 157, 343–347 (2007). https://doi.org/10.1007/s10354-007-0436-4
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10354-007-0436-4